Emergence of daptomycin-resistant VRE: experience of a single institution. Academic Article uri icon

Overview

abstract

  • Recent surveillance from US hospitals shows that more than 99.5% of vancomycin-resistant enterococci (VRE) isolates remain susceptible to daptomycin. This report describes emergence of daptomycin-resistant VRE at a major cancer center. The percentage of patients with daptomycin-resistant VRE bacteremia increased from 3.4% in 2007 to 15.2% in 2009 ([Formula: see text]). Without susceptibility data, empiric daptomycin therapy for VRE infections should be used with caution.

publication date

  • April 1, 2011

Research

keywords

  • Anti-Bacterial Agents
  • Daptomycin
  • Drug Resistance, Multiple, Bacterial
  • Enterococcus faecium
  • Gram-Positive Bacterial Infections

Identity

PubMed Central ID

  • PMC3676937

Scopus Document Identifier

  • 79952611743

Digital Object Identifier (DOI)

  • 10.1086/659152

PubMed ID

  • 21460492

Additional Document Info

volume

  • 32

issue

  • 4